tirzepatide fda regulations What are the changes to this month? FDA Grants Tirzepatide a New

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review

How to Calculate the C Rating of a Lithium Polymer Battery

That applies in telehealth too

Danuglipron, developed by Pfizer, showed 813% placebo-adjusted weight loss in Phase IIb studies, though high discontinuation rates highlight ongoing challenges with GI tolerability and formulation [87, 88]

Dual-modality nanoprobes combining GLP-1R-based PET and T1-weighted MRI enable noninvasive quantification of -cell mass, with potential application in therapeutic monitoring and patient stratification [451, 452]